PALACE: Cemiplimab Trial According to ctDNA Levels

Clinical trial NCT06917573 · RECRUITING

Trial details

NCT number: NCT06917573
Sponsor: Fundación GECP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Metastatic Lung Diseases Stage IV Non-small Cell Lung Cancer Stage III Non-small Cell Lung Cancer Respiratory Tract Neoplasms Thoracic Neoplasms

Start date: 2025-07-29
Primary completion: 2031-12-30
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.